Omega-3 may reduce risk of Alzheimer’s: Rat study

By Stephen Daniells

- Last updated on GMT

Related tags: Omega-3 fatty acid, Alzheimer's disease

The omega-3 compound ethyl-eicosapentaenoic acid (E-EPA) may improve memory and learning, and reduce the risk of Alzheimer´s disease, says a new study.

Researchers from Canada and Thailand report that, while levels of the neurotransmitter acetylcholine decrease with age, E-EPA may slow this decline, according to findings published in the Journal of Neurochemistry​.

“This study, for the first time, reported […] a clear correlation between the decrease in acetylcholine release and memory deficit, [and] E-EPA improves memory by attenuating the reduction of acetylcholine release and nerve growth factor expression,”​ wrote Pornnarin Taepavarapruk from Naresuan University, Thailand and Cai Song from the University of Prince Edwards Island, Canada.

Omega-3 and brain health

The link between omega-3 and cognitive function is not new, with various studies reporting somewhat conflicting results for the omega-3 fatty acids EPA and DHA (docosahexaenoic acid).

Some of the more promising data has been reported for DHA, with memory function improvements found for healthy older adults with a decline in cognitive function that occurs naturally with age. Such decline is known to precede diseases such as Alzheimer's, the most common form of dementia and currently affects over 13 million people worldwide.

However, according to data presented at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna last year, DHA supplements may not benefit people already suffering from Alzheimer’s disease.

Potential for EPA?

Using Amarin Neuroscience’s ethyl-EPA or palm oil (control), the researchers supplemented rat chow with 0.8 per cent of the oil.

Data showed that, in the palm oil supplemented animals, the release of acetylcholine decreased. In addition, a decrease in the expression of nerve growth factor (NGF) in the hippocampus was correlated with this reduced acetylcholine release. Both of these were associated with memory impairment, said the researchers.

Animals supplemented with E-EPA, however, showed improved memory, linked to attenuation in the reduction of acetylcholine release and NGF release.

“In this study, our findings add further evidence that E-EPA may improve memory by the modulation of acetylcholineand neurotrophin functions,”​ said the researchers.

The study was supported by the Canadian Institutes for Health Research (CIHR), Amarin Neurosciences Ltd. and Atlantic Innovation Foundation.

Source: Journal of Neurochemistry
February 2010, Volume 112, Issue 4, Pages 1054-1064
“Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment”
Authors: P. Taepavarapruk, C. Song

Related news

Related products

show more

DHA ORIGINS™: The sustainable potential of algae.

DHA ORIGINS™: The sustainable potential of algae.

Fermentalg | 22-Jun-2020 | Technical / White Paper

Consumers find out about nutritional quality by closely scrutinizing the labeling and list of ingredients (clean label). They are interested in the provenance...

Natreon Immunity White Paper

Natreon Immunity White Paper

Natreon Inc. | 09-Jun-2020 | Technical / White Paper

Read through Natreon’s White Paper on Immunity Support to learn more about how Ayurvedic ingredients, Sensoril® Ashwagandha, Capros® Amla, and PrimaVie®...

New Research Exploring Cognition with Resveratrol

New Research Exploring Cognition with Resveratrol

Evolva | 01-Jun-2020 | Technical / White Paper

Newly published clinical research indicates that resveratrol can be an effective ingredient for maintaining memory and executive function of the brain...

Related suppliers

Follow us


View more